Search

Displaying results 4801 - 4810 of 10000 in total
  1. Drug

    Sulbactam pivoxil

    go.drugbank.com/drugs/DB15761
    Investigational

    Mixtures: EUMOXIN® DUO FORTE, TRIFAMOX IBL DUO® COMPRIMIDOSCategories: Heterocyclic Compounds, 2-Ring
  2. Drug

    Benzyl nicotinate

    go.drugbank.com/drugs/DB15764
    Investigational

    Mixtures: THERMO RHEUMON 100 MG/G + 10 MG/G KREM, 50 G, HOTFİX 100 MG/G + 10 MG/G KREM , 50 GRAMCategories: Heterocyclic Compounds, 1-Ring
  3. Drug

    CA-170

    go.drugbank.com/drugs/DB15772
    Investigational

    CA-170 is a selective, small molecule inhibitor of PD-L1.

  4. Drug

    Hu-rhEGF-rP64k/Mont

    go.drugbank.com/drugs/DB15781
    Investigational

    Hu-rhEGF-rP64k/Mont is a therapeutic vaccine composed by an antigen (recombinant human EGF (rhEGF) chemically conjugated to recombinant P64K (rP64K)) and an adjuvant (Montanide ISA51VG) being investigated

    Products: CIMAVAX®EGF
  5. Drug

    Zinc phenolsulfonate

    go.drugbank.com/drugs/DB15793
    ApprovedWithdrawn

    Synonyms: Zinc p-phenolsulfonate, Zinc p-phenolsulphonateMixtures: Racord Two 7, Siltrax Plus 7
  6. Drug

    VPM1002

    go.drugbank.com/drugs/DB15801
    Investigational

    This vaccine’s urease C gene is replaced with the listeriolysin O encoding gene from Listeria monocytogenes. … By reducing urease C, phagosome acidification can occur, promoting phagolysosome fusion while also providing the optimal low pH for listeriolysin O stability.

  7. Drug

    AV-COVID-19

    go.drugbank.com/drugs/DB15802
    Investigational

    The monocytes are then differentiated in vitro into dendritic cells with IL-4 and GM-CSF, incubated with SARS-CoV-2 antigens prior to administration. … AV-COVID-19 is a vaccine composed of autologous dendritic cells loaded with SARS-CoV-2 antigens and with or without Granulocyte-macrophage colony-stimulating factor (GM-CSF).

  8. Drug

    SCB-2019

    go.drugbank.com/drugs/DB15805
    Investigational

    SCB-2019 is a recombinant trimeric S protein subunit vaccine candidate being investigated against COVID-19. … As of June 2020, the company is pursuing a randomized, double blind, placebo controlled study (NCT04405908) to test the safety and immunogenicity of the vaccine.

  9. Drug

    CoronaVac

    go.drugbank.com/drugs/DB15806
    Investigational

    It was developed by propagating the SARS-CoV-2 CN2 strain inside Vero Cells and inactivating it with B-propiolactone[A219481;A219758]. … CoronaVac, previously known as PiCoVacc, is a SARS-CoV-2 purified, inactivated, and adsorbed vaccine candidate developed by SinoVac Biotech Corporation[A219758].

  10. Drug

    BBIBP-CorV

    go.drugbank.com/drugs/DB15807
    Investigational

    BBIBP-CorV vaccine contains a SARS-CoV-2 strain inactivated inside Vero Cells. … Investigation shows this vaccine induces neutralizing antibodies in several mammalian species while also showing protective efficacy with SARS-CoV-2 challenge in rhesus macaques[A219763].

    Synonyms: Purified inactivated SARS-CoV-2 Vaccine